Cite
Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.
MLA
Isfordink, Cas, et al. “Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.” Open Forum Infectious Diseases, vol. 9, no. 10, Oct. 2022, pp. 1–7. EBSCOhost, https://doi.org/10.1093/ofid/ofac508.
APA
Isfordink, C., Boyd, A., Mocroft, A., Kusejko, K., Smit, C., Wit, S. de, Mahungu, T., Falconer, K., Wandeler, G., Cavassini, M., Stöckle, M., Schinkel, J., Rauch, A., Peters, L., van der Valk, M., & EuroSIDA, for. (2022). Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study. Open Forum Infectious Diseases, 9(10), 1–7. https://doi.org/10.1093/ofid/ofac508
Chicago
Isfordink, Cas, Anders Boyd, Amanda Mocroft, Katharina Kusejko, Colette Smit, Stephane de Wit, Tabitha Mahungu, et al. 2022. “Low Risk of Failing Direct-Acting Antivirals in People With Human Immunodeficiency Virus/Hepatitis C Virus From Sub-Saharan Africa or Southeastern Asia: A European Cross-Sectional Study.” Open Forum Infectious Diseases 9 (10): 1–7. doi:10.1093/ofid/ofac508.